Skorpios Trust 13F annual report

Skorpios Trust is an investment fund managing more than $147 billion ran by Androulla Papadopoulou. There are currently 2 companies in Papadopoulou’s portfolio. The largest investments include Stoke Therapeutics and Spdr Ser Tr, together worth $147 billion.

$147 billion Assets Under Management (AUM)

As of 29th July 2024, Skorpios Trust’s top holding is 10,843,681 shares of Stoke Therapeutics currently worth over $146 billion and making up 99.9% of the portfolio value. Relative to the number of outstanding shares of Stoke Therapeutics, Skorpios Trust owns less than 0.3% of the company. In addition, the fund holds 1,686 shares of Spdr Ser Tr worth $156 million.

Currently, Skorpios Trust's portfolio is worth at least $147 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Skorpios Trust

The Skorpios Trust office and employees reside in Limassol, Cyprus. According to the last 13-F report filed with the SEC, Androulla Papadopoulou serves as the Director at Skorpios Trust.

Recent trades

Androulla Papadopoulou disclosed a decreased stake in Stoke Therapeutics by 0.2%. This leaves the value of the investment at $146 billion and 10,843,681 shares.

One of the smallest hedge funds

The two most similar investment funds to Skorpios Trust are Aspire Wealth Management Corp and Farrow. They manage $147 billion and $147 billion respectively.

Androulla Papadopoulou investment strategy

Skorpios Trust’s portfolio is diversified across 2 sectors. Currently, their heaviest sector is Health Care — making up 99.9% of the total portfolio value. The fund focuses on investments in the United States as 50.0% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up approximately 0.1% of the total holdings value. On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio. The average market cap of the portfolio companies is close to $330 million.

The complete list of Skorpios Trust trades based on 13F SEC filings

These positions were updated on August 5th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security	Shares Owned	Value	Allocation
Stoke Therapeutics, Inc.	24.92% 10,843,681	$146,498,130,000	99.89%
Spdr Ser Tr	No change 1,686	$156,309,000	0.11%
No transactions found
Showing first 500 out of 2 holdings